IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management IV, LLC

Q1 2021 Holdings

Filed 2021-05-17 | 13 holdings | $164.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics, Inc.(ACRS)COM00461U105$85.7M3,399,03452.0%
ALX Oncology Holdings Inc.(ALXO)COM00166B105$58.0M785,94535.2%
Cytokinetics Incorporated(CYTK)COM23282W605$20.5M881,90112.4%
Kinnate Biopharma Inc.COM49705R105$301.4K9,671,6430.2%
Pharvaris N.V.(PHVS)COMN69605108$91.3K3,261,9260.1%
Keros Therapeutics, Inc.(KROS)COM492327101$85.1K1,382,6410.1%
Relay Therapeutics, Inc.(RLAY)COM75943R102$74.0K2,139,3800.0%
Kura Oncology, Inc.(KURA)COM50127T109$52.3K1,849,9470.0%
Nurix Therapeutics, Inc.(NRIX)COM67080M103$38.5K1,238,4560.0%
Olema Pharmaceuticals, Inc.(OLMA)COM68062P106$13.0K393,0300.0%
Cymabay Therapeutics, Inc.(CBAYUSD)COM23257D103$8.1K1,787,0940.0%
Therapeutics Acquisition CorpCOM CL A88339T103$3.7K350,0000.0%
Decibel Therapeutics, Inc.COM24343R106$3.4K297,7110.0%